A promising therapy that treats blood cancers by harnessing the power of the immune system to target and destroy cancer cells could now treat solid tumors...
Fewer than one percent of people who get the flu every year get tested, in part because most tests require trained personnel and expensive equipment. Now...
TOPLINE: A single dose of EDIT-101, a CRISPR-associated protein 9 (Cas9)-based gene-editing therapy, appears safe and improves vision and sensitivity to light in patients with retinal...